Shanghai MicuRx Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 688373?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	8,307,401	1.27%
VC/PE Firms	38,579,770	5.89%
Individual Insiders	75,630,618	11.5%
Institutions	165,411,527	25.2%
General Public	172,241,137	26.3%
Private Companies	195,039,631	29.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 71.8% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.9%	Genie Pharma	71,572,817	CN¥347.8m	0%	no data
10.8%	MicuRx Pharmaceuticals, Inc.	70,756,084	CN¥343.9m	0%	no data
10.5%	Chong Yu Hou	68,752,718	CN¥334.1m	0%	no data
5.89%	Shanghai GP Healthcare Equity Investment Management Co., Ltd.	38,579,770	CN¥187.5m	0%	no data
4.47%	Huagai Capital Co., Ltd.	29,320,254	CN¥142.5m	0%	100.0%
3.76%	Legend Capital Management Co., Ltd.	24,624,825	CN¥119.7m	-3.14%	1.26%
2.8%	GP TMT Holdings Limited	18,371,317	CN¥89.3m	0%	no data
2.66%	China Universal Asset Management Company Ltd.	17,455,233	CN¥84.8m	-9.54%	0.04%
2.32%	Xinyi Youmai Kesi Financial Consulting Center (Limited Partnership)	15,217,545	CN¥74.0m	0%	no data
2.12%	Zhong Ou Fund Management Co., Ltd	13,891,331	CN¥67.5m	0%	0.04%
1.68%	Ningbo Jize Enterprise Management Partnership Enterprise (Limited Partnership)	10,976,915	CN¥53.3m	-18.1%	no data
1.55%	Shanghai Hanxin Jinghong Investment Management Co., Ltd.	10,151,445	CN¥49.3m	0%	no data
1.51%	Founder H Fund Co., Ltd.	9,866,157	CN¥47.9m	0%	6.96%
1.4%	Nanjing Tongxing Yingdian Investment Management Co., Ltd.	9,185,659	CN¥44.6m	0%	no data
1.27%	Zhejiang Huahai Pharmaceutical Co., Ltd.	8,307,401	CN¥40.4m	0%	no data
1.24%	Bencao 3E Bioventures Limited	8,144,953	CN¥39.6m	0%	no data
1.11%	DT Capital Partners	7,286,505	CN¥35.4m	0%	37.74%
1.01%	Rongtong Fund Management Co. Ltd.	6,648,748	CN¥32.3m	0%	0.12%
1.01%	Yingke Innovation Asset Management Co., Ltd.	6,607,512	CN¥32.1m	0%	2.6%
0.78%	Yaojin (Shanghai) Private Equity Fund Management Co., Ltd.	5,128,415	CN¥24.9m	0%	45.52%
0.74%	ABC-CA Fund Management Co., Ltd.	4,873,686	CN¥23.7m	0%	0.09%
0.71%	Zhongtai Venture Capital (Shanghai) Co., Ltd.	4,650,961	CN¥22.6m	0%	1.3%
0.67%	Korea Investment Partners (Shanghai) Venture Capital Management Co., Ltd.	4,371,903	CN¥21.2m	0%	no data
0.47%	Golden Trust SinoPac Fund Management Co., Ltd.	3,069,821	CN¥14.9m	0%	0.14%
0.4%	Zhiyue Li	2,636,714	CN¥12.8m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/09 21:05
End of Day Share Price	2025/01/09 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai MicuRx Pharmaceutical Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Mingrui Wang	Everbright Securities Co. Ltd.